-
Grapefruit: The Healthy Fruit With a Potentially Dangerous DownsideThe health benefits of grapefruit are well known, but cancer patients should be aware of potentially harmful interactions it can have with common medicines.
by Anne Danahy
-
Thinking Outside the ClinicResearchers highlight need for outreach and educational programs to address survivorship disparities.
by Thomas Celona
-
Cultural Competence in the CommunityResearchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
by Kevin McLaughlin
-
Working Toward the End of Cancer Health DisparitiesAACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
by Eric Fitzsimmons
-
Chemotherapy Linked to Hearing Loss in AdultsGet your hearing checked periodically if you will be undergoing chemotherapy with neurotoxic effects.
by Sandra Gordon
-
The View From a CAR T-Cell Clinical TrialAfter exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
by Pamela Rafalow Grossman
-
Diet and Cancer: Getting the Research Onto Your PlateNew studies each year purport to show associations between certain foods and cancer. Experts say to focus on the big picture.
by Anne Danahy
-
How Common Are Treatment Breakthroughs?A new study adds nuance to the ‘golden age’ of cancer drug approvals.
by Jon Kelvey
-
New Guidelines Recommend Exercise for Most Cancer PatientsPeople in treatment for early-stage cancer should try to get exercise, according to new recommendations.
by Sandra Gordon
-
E-Cigarettes Don’t Live Up to PromisesNew studies find that electronic cigarettes trail other methods in helping people quit smoking, but they are growing in popularity among teens.
by Teresa Bergen
Scientists present data on the risks of immune checkpoint inhibitors so more patients can tap into the treatment.
by Marci A. Landsmann
Tissue and Liquid Biopsy for Targeted TherapyTailored treatments led to better outcomes than standard of care when biomarker results from liquid biopsy and tumor tissue aligned.
by Eric Fitzsimmons
Cancer Vaccines Show Promise in Early TrialsWhile mRNA vaccines offer a personalized approach to triggering an immune response, peptide vaccines could be a one-size-fits-all treatment. Researchers are exploring both options.
by Thomas Celona
Declining Breast Cancer Mortality in Younger WomenU.S. breast cancer deaths declined for women ages 20 to 49, which researchers credit to wider screening and better treatment.
by Kevin McLaughlin
-
Inaugural AACR IO Conference Kicks Off With Celebration of Immune CheckpointsImmune checkpoint icons James Allison and Arlene Sharpe shared their journeys and a look ahead on the opening night of the inaugural AACR IO conference.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
